Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Open-market sale President & CEO sold 3,775 shares at an average $0.36 ($1,344)
  2. 4 Open-market sale CFO, Sec'y & Treasurer sold 992 shares at an average $0.36 ($353)
  3. 4 Exercise or conversion Director acquired 26,368 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 46,686 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 46,686 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Accounting Officer sold 3,630 shares at $0.92 ($3,355)
  12. 4 Open-market sale Chief Development Officer sold 16,748 shares at $0.92 ($15,479)
  13. 4 Open-market sale Chief Commercial Officer sold 17,527 shares at $0.92 ($16,198)
  14. 4 Open-market sale President & CEO sold 83,660 shares at $0.92 ($77,319)
  15. 4 Open-market sale CFO, Sec'y & Treasurer sold 24,664 shares at $0.92 ($22,794)
  16. 4 Open-market buy Director bought 100,000 shares at $1.23 ($122,840)
  17. 4 Open-market buy Director bought 35,000 shares at $1.16 ($40,562)
  18. 4 Open-market buy Director bought 200,000 shares at $1.17 ($234,000)
  19. 4 Open-market sale Chief Accounting Officer sold 203 shares at an average $1.40 ($283)
  20. 4 Open-market sale Chief Development Officer sold 427 shares at an average $1.40 ($596)

Page 4 of 17 · 336 filings